A selection of striking news photographs taken around the world this week. A selection of the week's best photos from across the African continent and beyond. A selection of the week's best photos ...

Oct 8 (Reuters) - GSK (GSK.L), opens new tab said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in its third season after patients ...

These autumn photos will make you crave apple cider and plan your visit to the pumpkin patch The fall foliage at Falling Water Falls in Ozark National Forest in Arkansas is breathtaking.

Oct 4 (Reuters) - GSK (GSK.L), opens new tab, Sanofi (SASY.PA), opens new tab and CSL Ltd (CSL.AX), opens new tab have secured $72 million from the U.S. government to ramp up production of bird ...

As NFL officials touted a record low of preseason concussions Friday, they pledged that the league won't impose an outcome for its most notable concussion patient. Dolphins quarterback Tua ...

GSK Plc, Sanofi, and CSL Ltd. secured $72 million from the US government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to several human ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

Copyright 2024 The Associated Press. All Rights Reserved. A young supporter arrives before Republican presidential nominee former President Donald Trump at a campaign ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares closed yesterday at p1,497. ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £18.00. The company’s shares closed yesterday at p1,497. ...

GSK’s Vi­iV Health­care has sus­pend­ed de­vel­op­ment of a Phase 2-stage HIV an­tivi­ral named VH3739937, a GSK spokesper­son con­firmed to End­points News on Tues­day.